A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
University of Washington
University of Washington
Mayo Clinic
Mayo Clinic
Thomas Jefferson University
Mayo Clinic
Assiut University
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
NRG Oncology
University of Southern California
Thomas Jefferson University
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
University of Washington
Vanderbilt-Ingram Cancer Center
Institut Bergonié
Centre Antoine Lacassagne
UNICANCER
Vanderbilt-Ingram Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Jiangsu Cancer Institute & Hospital
Al-Azhar University
M.D. Anderson Cancer Center
Universitaire Ziekenhuizen KU Leuven
M.D. Anderson Cancer Center
Indiana University
Mayo Clinic
Mayo Clinic
Oslo University Hospital
Thomas Jefferson University
University of Nebraska
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Alliance for Clinical Trials in Oncology
The Ottawa Hospital
National Cancer Institute, Egypt
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Jonsson Comprehensive Cancer Center
Assiut University
University of Southern California
Mayo Clinic
Iuliu Hatieganu University of Medicine and Pharmacy
Wake Forest University Health Sciences
University of Michigan
University of Michigan
Ottawa Heart Institute Research Corporation
NYU Langone Health